Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuke Qianjin Tablets
- Development stage
- Unknown
- Lead developer
- Zhuzhou Qianjin Pharmaceutical
- Modality
- Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Fuke Qianjin Tablets (妇科千金片) is an approved traditional Chinese patent medicine (TCM) developed by the Qianjin Research Institute (Zhuzhou Qianjin Pharmaceutical). It is formulated from eight herbal ingredients: Flemingia philippinensis (Philippine flemingia root), Rosa laevigata (Cherokee rose root), Andrographis paniculata, Mahonia fortunei (Chinese mahonia stem), Zanthoxylum dissitum, Angelica sinensis (Chinese angelica root), Spatholobus suberectus (suberect spatholobus), and Codonopsis pilosula (tangshen root). Fuke Qianjin Tablets are widely used in China for clearing heat, expelling dampness, tonifying qi, and resolving blood stasis. It is primarily indicated for gynecological inflammatory conditions, including pelvic inflammatory disease (PID), endometritis, and chronic cervicitis, often presenting with symptoms such as leukorrhagia, abdominal pain, and fatigue.
- Brand names
- Fuke Qianjin CapsulesFuke Qianjin TabletsQianjin
- Other names
- FKQJFuke Qianjin Pian妇科千金片
02
Targets
PI3K (Phosphoinositide-3-kinase regulatory subunit 6)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)TLR4 (Toll-like receptor 4)AKT (RAC-alpha serine/threonine-protein kinase)RELA (Nuclear Factor Kappa B Subunit p65)
Beyond the preview
Go deeper on Fuke Qianjin Tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fuke Qianjin Tablets.